α2-macroglobulin enhances vasculogenesis/angiogenesis of mouse embryonic stem cells by stimulation of nitric oxide generation and induction of fibroblast growth factor-2 expression

Stem Cells and Development

Volumn 22, Issue 9, 2013, Pages 1443-1454

  Sauer, Heinrich ^a   Ravindran, Febina ^a   Beldoch, Matthias ^a   Sharifpanah, Fatemeh ^a   Jedelská, Jamila ^b   Strehlow, Boris ^b   Wartenberg, Maria ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; 4,5 DIAMINOFLUORESCEIN DIACETATE; ALPHA 2 MACROGLOBULIN; ALPHA SMOOTH MUSCLE ACTIN; ANTIBODY; CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; EMBRYONIC STEM CELL; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ALPHA-MACROGLOBULINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHICK EMBRYO; EMBRYOID BODIES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICE, 129 STRAIN; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, LDL; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84876950098     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0640     Document Type: Article

References (40)

1. Crook M, M Haq, S Haq & P Tutt. (1994). Plasma sialic acid & acute-phase proteins in patients with myocardial infarction. Angiology 45:709-715.
2. Stancic V, MB Beslin, M Matejcic, A Gopcevic, B Seni, M Peric, J Resetic, M Bergovec, V Heitzler Nikolic & M Koprcina. (1994). Comparison of the postoperative fibrinogen, alpha-1-antitrypsin & alpha-2-macroglobulin concentrations in the blood of wounded soldiers of Croatian Army & peacetime injured civilians. Wien Med Wochenschr 144:416-419.
3. Jinbo T, T Sakamoto & S Yamamoto. (2002). Serum alpha2-macroglobulin & cytokine measurements in an acute inflammation model in rats. Lab Anim 36:153-157.
4. Jinbo T, M Motoki & S Yamamoto. (2001). Variation of serum alpha2-macroglobulin concentration in healthy rats and rats inoculated with Staphylococcus aureus or subjected to surgery. Comp Med 51:332-335.
5. Abe K, K Yamamoto & H Sinohara. (1989). Proteinase inhibitory spectrum of mouse murinoglobulin & alphamacroglobulin. J Biochem 106:564-568.
6. Hibbetts K, B Hines & D Williams. (1999). An overview of proteinase inhibitors. J Vet Intern Med 13:302-308.
7. Schaller J & SS Gerber. (2011). The plasmin-antiplasmin system: structural & functional aspects. Cell Mol Life Sci 68:785-801.
8. Kaczowka SJ, LS Madding, KL Epting, RM Kelly, GJ Cianciolo and SV Pizzo. (2008). Probing the stability of native and activated forms of alpha2-macroglobulin. Int J Biol Macromol 42:62-67.
9. Strickland DK & S Ranganathan. (2003). Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemost 1:1663-1670.
10. Lillis AP, I Mikhailenko & DK Strickland. (2005). Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J Thromb Haemost 3:1884-1893.
11. Lillis AP, LB Van Duyn, JE Murphy-Ullrich & DK Strickland. (2008). LDL receptor-related protein 1: unique tissuespecific functions revealed by selective gene knockout studies. Physiol Rev 88:887-918.
12. Mathew S, S Arandjelovic, WF Beyer, SL Gonias & SV Pizzo. (2003). Characterization of the interaction between alpha2-macroglobulin & fibroblast growth factor-2: the role of hydrophobic interactions. Biochem J 374:123-129.
13. Descamps B & C Emanueli. (2012). Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vascul Pharmacol 56:267-279.
14. Swift MR & BM Weinstein. (2009). Arterial-venous specification during development. Circ Res 104:576-588.
15. Vittet D, MH Prandini, R Berthier, A Schweitzer, H Martin-Sisteron, G Uzan & E Dejana. (1996). Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 88:3424-3431.
16. Bautch VL, WL Stanford, R Rapoport, S Russell, RS Byrum and TA Futch. (1996). Blood island formation in attached cultures of murine embryonic stem cells. Dev Dyn 205:1-12.
17. Robertson E, A Bradley, M Kuehn & M Evans. (1986). Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323:445-448.
18. Ribatti D, B Nico, A Vacca & M Presta. (2006). The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 1:85-91.
19. Sauer H, MM Bekhite, J Hescheler & M Wartenberg. (2005). Redox control of angiogenic factors & CD31-positive vessellike structures in mouse embryonic stem cells after direct current electrical field stimulation. Exp Cell Res 304:380-390.
20. Bekhite MM, A Finkensieper, S Binas, J Muller, R Wetzker, HR Figulla, H Sauer & M Wartenberg. (2011). VEGFmediated PI3K class IA & PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells. J Cell Sci 124:1819-1830.
21. Padmasekar M, R Nandigama, M Wartenberg, KD Schluter and H Sauer. (2007). The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 & PI3-kinase/Akt pathways. Cardiovasc Res 75:118-128.
22. Milosevic N, MM Bekhite, F Sharifpanah, C Ruhe, M Wartenberg and H Sauer. (2010). Redox stimulation of cardiomyogenesis versus inhibition of vasculogenesis upon treatment of mouse embryonic stem cells with thalidomide. Antioxid Redox Signal 13:1813-1827.
23. Poole TJ, EB Finkelstein & CM Cox. (2001). The role of FGF and VEGF in angioblast induction & migration during vascular development. Dev Dyn 220:1-17.
24. Oehmichen M, V Schmidt & K Stuka. (1989). [Immunohistochemical assessment of survival from open skin wounds using paraffin sections]. Beitr Gerichtl Med 47:7-11.
25. Kataranovski M, Z Magic & N Pejnovic. (1999). Early inflammatory cytokine & acute phase protein response under the stress of thermal injury in rats. Physiol Res 48:473-482.
26. Grinnell F, M Zhu & WC Parks. (1998). Collagenase-1 complexes with alpha2-macroglobulin in the acute & chronic wound environments. J Invest Dermatol 110:771-776.
27. Ahrens I, H Domeij, D Topcic, I Haviv, RM Merivirta, A Agrotis, E Leitner, JB Jowett, C Bode, M Lappas & K Peter. (2011). Successful in vitro expansion & differentiation of cord blood derived CD34 + cells into early endothelial progenitor cells reveals highly differential gene expression. PLoS One 6:e23210.
28. Gaultier A, AM Salicioni, S Arandjelovic & SL Gonias. (2006). Regulation of the composition of the extracellular matrix by low density lipoprotein receptor-related protein-1: activities based on regulation of mRNA expression. J Biol Chem 281:7332-7340.
29. Makarova AM, TV Lebedeva, T Nassar, AA Higazi, J Xue, ME Carinato, K Bdeir, DB Cines & V Stepanova. (2011). Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase. J Biol Chem 286:23044-23053.
30. Everaert BR, EM Van Craenenbroeck, VY Hoymans, SE Haine, L Van Nassauw, VM Conraads, JP Timmermans and CJ Vrints. (2010). Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 144:350-366.
31. Duda DG, D Fukumura & RK Jain. (2004). Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med 10:143-145.
32. Amos S, M Mut, CG Dipierro, JE Carpenter, A Xiao, ZA Kohutek, GT Redpath, Y Zhao, J Wang, ME Shaffrey & IM Hussaini. (2007). Protein kinase C-alpha-mediated regulation of low-density lipoprotein receptor related protein and urokinase increases astrocytoma invasion. Cancer Res 67: 10241-10251.
33. Bekhite MM, A Finkensieper, FA Abou-Zaid, IK El Shourbagy, KM Omar, HR Figulla, H Sauer & M Wartenberg. (2010). Static electromagnetic fields induce vasculogenesis and chondro-osteogenesis of mouse embryonic stem cells by reactive oxygen species-mediated up-regulation of vascular endothelial growth factor. Stem Cells Dev 19:731-743.
34. Feraud O, Y Cao & D Vittet. (2001). Embryonic stem cellderived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest 81:1669-1681.
35. Lange S, J Heger, G Euler, M Wartenberg, HM Piper & H Sauer. (2009). Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovasc Res 81:159-168.
36. Gendron RL, FY Tsai, H Paradis & RJ Arceci. (1996). Induction of embryonic vasculogenesis by bFGF & LIF in vitro & in vivo. Dev Biol 177:332-346.
37. Mascetti V, S Mendjan, AS Bernardo, D Ortmann and RA Pedersen. (2011). 58 Wnt/{beta}-catenin signalling at the heart of cardiogenic mesoderm specification. Heart 97:e7.
38. Wartenberg M, F Donmez, FC Ling, H Acker, J Hescheler and H Sauer. (2001). Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J 15:995-1005.
39. Dennis PA, O Saksela, P Harpel & DB Rifkin. (1989). Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor. J Biol Chem 264:7210-7216.
40. Asplin IR, SM Wu, S Mathew, G Bhattacharjee & SV Pizzo. (2001). Differential regulation of the fibroblast growth factor (FGF) family by alpha(2)-macroglobulin: evidence for selective modulation of FGF-2-induced angiogenesis. Blood 97:3450-3457.